Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zeposia (ozanimod)
Biotech
Ventyx misses with investors amid comparisons to BMS, Pfizer
The phase 2 hit its primary endpoint, but doubts about whether the candidate has an edge over rival S1P1 modulators sent Ventyx’s stock down.
Nick Paul Taylor
Oct 10, 2023 6:30am
Chasing BMS and Pfizer, Connect fails ulcerative colitis trial
May 4, 2022 7:53am
Bristol Myers says Celgene buyout could boost sales to $20B
Jun 25, 2020 11:45am